Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
HCCF
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by Dardadog: [QB] Health/Medical Writers / Business Editors HUTCHINSON, Kan.--(BUSINESS WIRE)--HCCF-- HEE Corporation ('HCCF' on OTC Pink Sheets) is pleased to report that the results of a Hemoglobin A1c Test (HbA1c) conducted on test subject Ron Brooks on September 8, 2004, were excellent. The HbA1c test, which most physicians regard as the most dependable measure of a patient's blood sugar level, provides an accurate blood sugar average over a 90-day period, and is the most comprehensive and representative reading of an individual's overall blood sugar level. Mr. Brooks' blood sugar reading on the September 8th test was an astounding 6.7%, down significantly from his August 3, 2004 reading of 7.5%, and exceeding by a very comfortable margin the common goal of achieving a reading of less than 7%. Ron Brooks continues, of course, to take a maintenance dose of the Company's Type II Diabetes treatment. Coupled with the extraordinary improvement in both test subjects' daily blood sugar levels during the eight-week treatment period, Mr. Brook's latest HbA1c test reinforces the very positive interim results of the 8-week trial, and serves to enhance the promise that has been clearly demonstrated to date by HEE Corp's homeopathic treatment for Type II Diabetes. HEE Launches New Website HEE Corp. is also proud to announce the launch of its new, more comprehensive, yet user-'friendlier' website which provides extensive information concerning Type II Diabetes, as well as timely information on HEE's corporate activities. The site offers valuable Investor Relations information, including a link to live stock quotes, and has a Media Section that archives corporate News Releases and Media Interviews with management. This Media Section will be expanded over time to include forthcoming TV interviews with HEE Corp. management, pertinent Newspaper articles, etc. The recent interview with "It's About Finance.com" filmed on the floor of the Chicago Stock Exchange is currently on the new website. We urge interested parties to visit the site often to keep abreast of HEE Corporation developments, including additional test results during this very exciting period in the Company's development. About HEE Corporation An emerging-growth healthcare company, the HEE Corporation was initially founded for the purpose of testing and marketing a new and extremely promising homeopathic treatment for Type II Diabetes. HEE has acquired the worldwide distribution rights for this diabetic treatment. In the United States alone, 18.2 million people have diabetes and, unfortunately, 5.2 million (nearly one-third of that total) are not yet aware that they have it! Diabetes is the fifth leading cause of death by disease in the US. Now a modern-day epidemic, some 171,000,000 people around the globe are estimated to have diabetes (mostly Type II) and the costs of treatment and productivity losses now run into the hundreds of billions of dollars worldwide. Early indications from the Company's current phase of treatment and testing have been extremely positive, holding out great promise that a cure for Type II Diabetes may be in sight. The recently announced acquisition of the Halstead Hospital and Hertzler Clinic in Kansas represents another important step forward in HEE Corp's growth plans in the dynamic, multibillion-dollar healthcare industry. NOTE: Safe Harbor for Forward-Looking Statements--Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation and risk inherent in the company's international operations. KEYWORD: KANSAS INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MEDICAL E-COMMERCE INTERNET PRODUCT SOURCE: HEE Corporation CONTACT INFORMATION: HEE Corporation Shannon Meyer, 620-663-3333 [URL=http://www.hee-corp.com]www.hee-corp.com[/URL] [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2